Research and Development

Showing 15 posts of 9607 posts found.

epi-pen_1_3

EpiPen shortage hits UK and Canada hard, but not US

April 18, 2018 Research and Development, Sales and Marketing Mylan, Pfizer, biotech, drugs, epipen, pharma, pharmaceutical

Manufacturing issues at the single Pfizer plant that produces the EpiPen epinephrine injector has caused serious shortages in the UK …
amgen_flag

Amgen and Novartis’ Aimovig shines in migraine at Phase 3

April 18, 2018 Research and Development Aimovig, Amgen, Novartis, migraine, pharma

Amgen has lifted the curtain on complete Phase 3 data for its calcitonin gene-related peptide receptor (CGRP) inhibitor Aimovig (erenumab) in …
jerome_contamine_770x510

Sanofi CFO set to step down this year

April 18, 2018 Medical Communications, Research and Development Sanofi, biotech, cfo, drugs, pharma, pharmaceutical

After a busy start to the year, with a number of acquisitions and a few divestments, Sanofi’s Chief Financial Officer, …
gw_pharma

All indications point to approval for cannabis-based therapy

April 17, 2018 Research and Development, Sales and Marketing FDA, GW Pharma, biotech, drugs, pharma, pharmaceutical

GW Pharma are inching step by step towards a likely approval with the FDA, after it received a strong recommendation …
novartis_outside_1

Novartis to invest $100m in new malaria treatments

April 17, 2018 Manufacturing and Production, Research and Development Novartis, WHO, malaria, pharma

Novartis has revealed it is to invest $100 million into the research and development of new treatments for malaria over …
merckwindow_web

Keytruda success continues, beating Opdivo in lung cancer survival

April 17, 2018 Manufacturing and Production, Research and Development Cancer, MSD, NSCLC, keytruda, lung cancer, pharma

Not content with revealing two strong waves of data on its flagship immunotherapy Keytruda (pembrolizumab) over the past weeks, MSD …
pharmacy-3087596_960_720

Care packaging: Inside the Falsified Medicines Directive

April 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, packaging, pharma, pharmaceutical

When it comes to the pharmaceutical supply chain, patient safety has and will always be a primary concern for all …
novartis_outside_1

Novartis’ Entresto helps preserve kidney function in chronic heart failure patients

April 16, 2018 Research and Development, Sales and Marketing Entresto, Novartis, heart failure, pharma

Novartis has lifted the curtain on new data from a Phase 3 trial investigating the efficacy of Entresto (sacubitril/valsartan) in …

J&J’s ketamine nasal spray for depression continues to impress

April 16, 2018 Research and Development, Sales and Marketing Johnson & Johnson, Ketamine, biotech, drugs, pharma, pharmaceutical

New treatments for depression are few and far between; pharmaceutical companies have shied away from trying to develop new therapeutics …
merckentranceweb

Keytruda continues success with new Phase 3 data in adjuvant melanoma

April 16, 2018 Research and Development, Sales and Marketing Cancer, MSD, keytruda, melanoma, pharma, skinc cancer

MSD has revealed new efficacy data for Keytruda (permbrolizumab) as an adjuvant therapy in the treatment of resected, high-risk stage …

Visit Us! DIA’s Refreshed Homepage Design

April 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

We’re excited to share with you our recently redesigned homepage, at the same site address: DIAglobal.org. The main objectives of …

PrimeVigilance celebrates its 10th anniversary

April 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing primevigilance

PrimeVigilance will be exhibiting and celebrating its 10th anniversary at #DIAEurope2018, raffling 10 bottles of champagne away! Stop by their …
shutterstock_79370437

Hanmi terminates lung cancer drug after being muscled out by AZ’s Tagrisso

April 13, 2018 Medical Communications, Research and Development AstraZeneca, Cancer, Otila, Tagrisso, hanmi, lung cancer, pharma

South Korea’s Hanmi Pharmaceutical has announced its intention to terminate development of its lung cancer drug Olita (olmutinib) as it …
180405-evolution-of-kidney-cancer

Evolutionary path of kidney cancer tracked, “born to be bad” type discovered

April 13, 2018 Medical Communications, Research and Development Kidney cancer, biotech, drugs, pharma, pharmaceutical

A massive effort funded by Cancer Research UK has been able to track the different evolutionary pathways of kidney cancer …
The Gateway to Local Adoption Series

Latest content